Financial Performance - For the fiscal year 2023, total revenue decreased by 13.76% to approximately 86.55million,downfrom100.35 million in 2022[17]. - In Q4 2023, total revenue decreased by 1.91% to approximately 20.96million,comparedto21.37 million in Q4 2022[3]. - Total revenue decreased by 13.67million,or13.6686.41 million for the year ended December 31, 2023, compared to 100.08millionfor2022[21].−TotalrevenuesfortheyearendedDecember31,2023,were86,546,950, a decrease of 13.7% from 100,352,434in2022[43].Profitability−GrossprofitforQ42023wasapproximately0.25 million, a decrease of 75.61% from 1.03millioninQ42022,resultinginagrossmarginof1.193.75 million, or 78.97%, to approximately 1.00million,resultinginagrossmarginof1.16999,885, down 79.0% from 4,754,196in2022[43].NetLoss−ThenetlossforQ42023wasapproximately3.98 million, or a loss of 0.40pershare,comparedtoanetlossof11.91 million, or a loss of 1.19pershare,inQ42022[12].−Netlossincreasedby6.63 million, or 39.98%, to approximately 9.95millionfortheyearendedDecember31,2023,withalosspershareof0.99[28]. - Net loss for 2023 was 9,946,035,comparedtoanetlossof16,571,308 in 2022, representing a 40.0% improvement[43]. - Basic and diluted losses per share improved to (0.99)in2023from(1.66) in 2022[43]. EBITDA - EBITDA for Q4 2023 was approximately 0.11million,asignificantdecreaseof97.083.77 million in Q4 2022[13]. - EBITDA decreased by 5.35million,or48.815.61 million for the year ended December 31, 2023, compared to 10.96millionfor2022[29].Expenses−Selling,generalandadministrativeexpensesincreasedby122.803.38 million in Q4 2023, up from 1.52 million in Q4 2022[12]. - SG&A expenses decreased by 0.98 million, or 9.78%, to approximately 9.08millionfortheyearendedDecember31,2023[27].RevenueBreakdown−RevenuefromregularCorrugatingMediumPaper(CMP)decreasedby1.5217.02 million in Q4 2023, with an average selling price (ASP) of 362pertonne[9].−Revenuefromtissuepaperproductsincreasedby87.040.47 million in Q4 2023, with an ASP of 987pertonne[10].−RevenuefromregularCMPdecreasedby14.93 million, or 18.14%, to approximately 67.37million,whilerevenuefromlight−weightCMPdecreasedby1.91 million, or 11.61%, to approximately 14.52millionfortheyearendedDecember31,2023[22].−Revenuefromfacemasksdecreasedby0.15 million, or 58.86%, to approximately 0.11millionfortheyearendedDecember31,2023[25].CashFlowandAssets−Cashandbankbalancesdecreasedtoapproximately3.92 million as of December 31, 2023, down from 9.52millionattheendof2022[32].−Currentassetsdecreasedtoapproximately28.36 million, while current liabilities increased to approximately 21.42million,resultinginworkingcapitalofapproximately6.94 million as of December 31, 2023[33]. - Net cash provided by operating activities increased to approximately 12.87millionfortheyearendedDecember31,2023,comparedto10.72 million for 2022[34]. - Total current assets decreased to 28,357,901in2023from47,166,475 in 2022, a decline of 39.8%[40]. - Cash and bank balances at the end of 2023 were 3,918,938,downfrom9,524,868 at the end of 2022, a decrease of 58.8%[46]. - Net cash provided by operating activities for 2023 was 12,871,086,anincreasefrom10,719,388 in 2022[45]. - Cash used in investing activities was 22,239,297in2023,comparedto10,898,531 in 2022, indicating increased capital expenditures[45]. Strategic Focus - The company plans to focus on acquiring new customers and improving efficiency while implementing flexible pricing strategies to adapt to market trends[2].